vs
纽约时报公司（NYT）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
纽约时报公司的季度营收约是Royalty Pharma plc的1.3倍（$802.3M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 16.2%，领先18.3%），纽约时报公司同比增速更快（10.4% vs 4.8%），过去两年纽约时报公司的营收复合增速更高（16.2% vs 4.6%）
纽约时报公司是美国知名大众传媒企业，总部位于纽约市曼哈顿的纽约时报大厦，旗下核心出版产品包括《纽约时报》及其国际版等系列刊物，同时运营多元媒体资产，在全球新闻传媒领域拥有较高知名度。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
NYT vs RPRX — 直观对比
营收规模更大
NYT
是对方的1.3倍
$622.0M
营收增速更快
NYT
高出5.6%
4.8%
净利率更高
RPRX
高出18.3%
16.2%
两年增速更快
NYT
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $802.3M | $622.0M |
| 净利润 | $129.8M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 20.1% | 62.4% |
| 净利率 | 16.2% | 34.4% |
| 营收同比 | 10.4% | 4.8% |
| 净利润同比 | 4.9% | 2.9% |
| 每股收益（稀释后） | $0.79 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NYTRPRX
| Q4 25 | $802.3M | $622.0M | ||
| Q3 25 | $700.8M | $609.3M | ||
| Q2 25 | $685.9M | $578.7M | ||
| Q1 25 | $635.9M | $568.2M | ||
| Q4 24 | $726.6M | $593.6M | ||
| Q3 24 | $640.2M | $564.7M | ||
| Q2 24 | $625.1M | $537.3M | ||
| Q1 24 | $594.0M | $568.0M |
净利润NYTRPRX
| Q4 25 | $129.8M | $214.2M | ||
| Q3 25 | $81.6M | $288.2M | ||
| Q2 25 | $82.9M | $30.2M | ||
| Q1 25 | $49.6M | $238.3M | ||
| Q4 24 | $123.7M | $208.2M | ||
| Q3 24 | $64.1M | $544.0M | ||
| Q2 24 | $65.5M | $102.0M | ||
| Q1 24 | $40.4M | $4.8M |
营业利润率NYTRPRX
| Q4 25 | 20.1% | 62.4% | ||
| Q3 25 | 15.0% | 70.1% | ||
| Q2 25 | 15.5% | 36.3% | ||
| Q1 25 | 9.2% | 94.0% | ||
| Q4 24 | 20.2% | 60.9% | ||
| Q3 24 | 12.0% | — | ||
| Q2 24 | 12.7% | 50.2% | ||
| Q1 24 | 8.1% | -13.0% |
净利率NYTRPRX
| Q4 25 | 16.2% | 34.4% | ||
| Q3 25 | 11.7% | 47.3% | ||
| Q2 25 | 12.1% | 5.2% | ||
| Q1 25 | 7.8% | 41.9% | ||
| Q4 24 | 17.0% | 35.1% | ||
| Q3 24 | 10.0% | 96.3% | ||
| Q2 24 | 10.5% | 19.0% | ||
| Q1 24 | 6.8% | 0.8% |
每股收益（稀释后）NYTRPRX
| Q4 25 | $0.79 | $0.49 | ||
| Q3 25 | $0.50 | $0.67 | ||
| Q2 25 | $0.50 | $0.07 | ||
| Q1 25 | $0.30 | $0.55 | ||
| Q4 24 | $0.74 | $0.46 | ||
| Q3 24 | $0.39 | $1.21 | ||
| Q2 24 | $0.40 | $0.23 | ||
| Q1 24 | $0.24 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $642.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.0B | $9.7B |
| 总资产 | $3.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资NYTRPRX
| Q4 25 | $642.2M | $618.7M | ||
| Q3 25 | $617.4M | $938.9M | ||
| Q2 25 | $540.2M | $631.9M | ||
| Q1 25 | $522.1M | $1.1B | ||
| Q4 24 | $565.9M | $929.0M | ||
| Q3 24 | $492.9M | $950.1M | ||
| Q2 24 | $411.4M | $1.8B | ||
| Q1 24 | $379.1M | $843.0M |
总债务NYTRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益NYTRPRX
| Q4 25 | $2.0B | $9.7B | ||
| Q3 25 | $2.0B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $1.9B | $10.3B | ||
| Q3 24 | $1.9B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
总资产NYTRPRX
| Q4 25 | $3.0B | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.8B | $18.3B | ||
| Q1 25 | $2.7B | $17.6B | ||
| Q4 24 | $2.8B | $18.2B | ||
| Q3 24 | $2.8B | $18.0B | ||
| Q2 24 | $2.7B | $17.7B | ||
| Q1 24 | $2.6B | $16.1B |
负债/权益比NYTRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $164.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $157.6M | — |
| 自由现金流率自由现金流/营收 | 19.6% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 1.26× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $550.5M | — |
8季度趋势，按日历期对齐
经营现金流NYTRPRX
| Q4 25 | $164.2M | $827.1M | ||
| Q3 25 | $207.6M | $702.6M | ||
| Q2 25 | $113.6M | $364.0M | ||
| Q1 25 | $99.1M | $596.1M | ||
| Q4 24 | $151.7M | $742.5M | ||
| Q3 24 | $125.5M | $703.6M | ||
| Q2 24 | $80.2M | $658.2M | ||
| Q1 24 | $53.1M | $664.6M |
自由现金流NYTRPRX
| Q4 25 | $157.6M | — | ||
| Q3 25 | $199.7M | — | ||
| Q2 25 | $103.3M | — | ||
| Q1 25 | $89.9M | — | ||
| Q4 24 | $143.6M | — | ||
| Q3 24 | $118.4M | — | ||
| Q2 24 | $72.6M | — | ||
| Q1 24 | $46.7M | — |
自由现金流率NYTRPRX
| Q4 25 | 19.6% | — | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 14.1% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | 11.6% | — | ||
| Q1 24 | 7.9% | — |
资本支出强度NYTRPRX
| Q4 25 | 0.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 1.1% | — |
现金转化率NYTRPRX
| Q4 25 | 1.26× | 3.86× | ||
| Q3 25 | 2.54× | 2.44× | ||
| Q2 25 | 1.37× | 12.06× | ||
| Q1 25 | 2.00× | 2.50× | ||
| Q4 24 | 1.23× | 3.57× | ||
| Q3 24 | 1.96× | 1.29× | ||
| Q2 24 | 1.22× | 6.45× | ||
| Q1 24 | 1.31× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NYT
| Subscription | $510.5M | 64% |
| Advertising | $191.7M | 24% |
| Affiliate Licensing And Other Products And Services | $100.2M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
